LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device …
Over the last 12 months, insiders at LivaNova PLC have bought $0 and sold $3.54M worth of LivaNova PLC stock.
On average, over the past 5 years, insiders at LivaNova PLC have bought $137,141 and sold $1.67M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,000 shares for transaction amount of $180,856 was made by KOZY WILLIAM A (director) on 2021‑11‑10.
2024-12-11 | Sale | director | 1,250 0.0023% | $50.99 | $63,738 | -2.81% | ||
2024-09-11 | Sale | director | 1,500 0.0027% | $46.58 | $69,870 | 0.00% | ||
2024-06-03 | Sale | director | 56,623 0.1044% | $60.11 | $3.4M | -14.06% | ||
2023-03-30 | Sale | CEO | 2,220 0.0041% | $42.55 | $94,461 | +17.82% | ||
2022-12-15 | Sale | CEO | 2,220 0.0042% | $54.56 | $121,123 | -8.09% | ||
2022-04-01 | Sale | 1,000 0.0018% | $83.42 | $83,416 | -33.78% | |||
2022-03-29 | Sale | CEO | 5,568 0.0104% | $81.50 | $453,792 | -31.51% | ||
2022-03-02 | Sale | 2,000 0.0038% | $80.00 | $160,000 | -26.43% | |||
2022-02-25 | Sale | director | 2,000 0.0037% | $80.00 | $160,000 | -27.47% | ||
2022-01-03 | Sale | director | 2,000 0.0037% | $85.93 | $171,868 | -27.21% | ||
2021-12-13 | Sale | CEO | 5,568 0.0104% | $81.50 | $453,792 | -21.03% | ||
2021-12-01 | Sale | director | 2,000 0.0038% | $81.73 | $163,468 | -19.25% | ||
2021-11-11 | Sale | director | 4,674 0.0088% | $89.17 | $416,794 | -23.90% | ||
2021-11-10 | Sale | director | 1,288 0.0024% | $90.77 | $116,906 | -25.85% | ||
2021-11-10 | director | 2,000 0.0037% | $90.43 | $180,856 | -25.85% | |||
2021-11-03 | Sale | director | 2,000 0.0036% | $85.25 | $170,500 | -21.97% | ||
2021-10-01 | Sale | director | 2,000 0.0037% | $80.00 | $160,000 | -7.45% | ||
2021-09-01 | Sale | director | 2,000 0.0038% | $82.40 | $164,803 | -6.51% | ||
2021-08-02 | Sale | director | 2,000 0.0038% | $86.39 | $172,777 | -9.11% | ||
2021-06-29 | Sale | director | 2,000 0.004% | $84.20 | $168,400 | -5.40% |
Novak Alfred J | director | 11368 0.0209% | $47.10 | 1 | 9 | +31.2% |
KOZY WILLIAM A | director | 6320 0.0116% | $47.10 | 2 | 0 | <0.0001% |
O'Kane Sharon | director | 1000 0.0018% | $47.10 | 1 | 0 | +38.71% |
BlackRock | $411.01M | 13.57 | 7.35M | -0.92% | -$3.83M | 0.01 | |
PRIMECAP Management Co | $332.12M | 10.96 | 5.94M | +2.52% | +$8.16M | 0.24 | |
Barrow Hanley Global Investors | $132.02M | 4.36 | 2.36M | -0.51% | -$675,139.86 | 0.45 | |
Millennium Management LLC | $127.49M | 4.21 | 2.28M | +4.13% | +$5.06M | 0.08 | |
State Street | $111.82M | 3.69 | 2M | +0.56% | +$623,898.82 | 0.01 |